Frontmatter

Home Frontmatter

Article Publicly Available

Published/Copyright: April 1, 2024

Published by

Become an author with De Gruyter Brill

Submit Manuscript Author Information Explore this Subject

"Frontmatter" Pleura and Peritoneum, vol. 9, no. 1, 2024, pp. i-ii. https://doi.org/10.1515/pp-2024-frontmatter1

(2024). Frontmatter. Pleura and Peritoneum, 9(1), i-ii. https://doi.org/10.1515/pp-2024-frontmatter1

(2024) Frontmatter. Pleura and Peritoneum, Vol. 9 (Issue 1), pp. i-ii. https://doi.org/10.1515/pp-2024-frontmatter1

"Frontmatter" Pleura and Peritoneum 9, no. 1 (2024): i-ii. https://doi.org/10.1515/pp-2024-frontmatter1

Frontmatter. Pleura and Peritoneum. 2024;9(1): i-ii. https://doi.org/10.1515/pp-2024-frontmatter1

Copied to clipboard

Published Online: 2024-04-01

Articles in the same Issue

Frontmatter
Review
Outcomes of minimal access cytoreductive surgery (M-CRS) and HIPEC/EPIC vs. open cytoreductive surgery (O-CRS) and HIPEC/EPIC in patients with peritoneal surface malignancies: a meta-analysis
Research Articles
Peritoneal metastases from rare ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC)
In vitro 3D microfluidic peritoneal metastatic colorectal cancer model for testing different oxaliplatin-based HIPEC regimens
Active surveillance for low-grade appendiceal mucinous neoplasm (LAMN)
Ascites does not accompany pleural effusion developing under dasatinib therapy in patients with CML-CP
Letter to the Editor
Implementation of ERAS guidelines in patients undergoing CRS and HIPEC: need for multicentre trial

Search journal Search the content of this journal

Frontmatter
Review
Outcomes of minimal access cytoreductive surgery (M-CRS) and HIPEC/EPIC vs. open cytoreductive surgery (O-CRS) and HIPEC/EPIC in patients with peritoneal surface malignancies: a meta-analysis
Research Articles
Peritoneal metastases from rare ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC)
In vitro 3D microfluidic peritoneal metastatic colorectal cancer model for testing different oxaliplatin-based HIPEC regimens
Active surveillance for low-grade appendiceal mucinous neoplasm (LAMN)
Ascites does not accompany pleural effusion developing under dasatinib therapy in patients with CML-CP
Letter to the Editor
Implementation of ERAS guidelines in patients undergoing CRS and HIPEC: need for multicentre trial